KOPP INVESTMENT ADVISORS LLC - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 199 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
KOPP INVESTMENT ADVISORS LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2015$219,000
-5.2%
8,692
+4.9%
0.10%
-3.9%
Q1 2015$231,000
-91.0%
8,287
-88.6%
0.10%
-89.2%
Q3 2013$2,578,000
+22.4%
72,755
-46.1%
0.95%
+15.1%
Q2 2013$2,106,000–134,915–0.82%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2015
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders